ATE540694T1 - Verfahren zur behandlung der thrombozytopenie mit monoklonalem ivig - Google Patents
Verfahren zur behandlung der thrombozytopenie mit monoklonalem ivigInfo
- Publication number
- ATE540694T1 ATE540694T1 AT01996390T AT01996390T ATE540694T1 AT E540694 T1 ATE540694 T1 AT E540694T1 AT 01996390 T AT01996390 T AT 01996390T AT 01996390 T AT01996390 T AT 01996390T AT E540694 T1 ATE540694 T1 AT E540694T1
- Authority
- AT
- Austria
- Prior art keywords
- ivig
- monoclonal
- treating thrombocytopenia
- thrombocytopenia
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24944100P | 2000-11-20 | 2000-11-20 | |
PCT/CA2001/001648 WO2002040047A2 (en) | 2000-11-20 | 2001-11-20 | Method for treating thrombocytopenia with monoclonal ivig |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE540694T1 true ATE540694T1 (de) | 2012-01-15 |
Family
ID=22943488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01996390T ATE540694T1 (de) | 2000-11-20 | 2001-11-20 | Verfahren zur behandlung der thrombozytopenie mit monoklonalem ivig |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040047862A1 (de) |
EP (2) | EP1370288B1 (de) |
AT (1) | ATE540694T1 (de) |
AU (1) | AU2002220404A1 (de) |
CA (2) | CA2856033C (de) |
DK (2) | DK2283861T3 (de) |
WO (1) | WO2002040047A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0314461D0 (en) * | 2003-06-20 | 2003-07-23 | Isis Innovation | Suppression of transplant rejection |
WO2005094880A1 (en) * | 2004-03-30 | 2005-10-13 | Canadian Blood Services | Method for treating autoimmune diseases with antibodies |
US8470318B2 (en) | 2005-11-07 | 2013-06-25 | The Rockefeller University | Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
US8597636B2 (en) | 2006-01-13 | 2013-12-03 | Canadian Blood Services | Method for treating autoimmune diseases and compositions therefor |
EP3456351A1 (de) | 2006-04-05 | 2019-03-20 | The Rockefeller University | Polypeptide mit verbesserten entzündungshemmenden und verminderten zytotoxischen eigenschaften und verfahren im zusammenhang damit |
US7846744B2 (en) | 2008-04-22 | 2010-12-07 | Ravetch Jeffrey V | Methods of identifying anti-inflammatory compounds |
US20150329639A1 (en) * | 2012-12-12 | 2015-11-19 | University Of Virginia Patent Foundation | Compositions and methods for regulating erythropoiesis |
CN112142843A (zh) | 2013-12-24 | 2020-12-29 | 阿尔金克斯有限公司 | FcRn拮抗剂及使用方法 |
MX2017011534A (es) | 2015-03-09 | 2018-04-10 | Argenx Bvba | Metodos para reducir los niveles de suero de agentes que contienen fc que usan antagonistas de fcrn. |
GB2589049C (en) | 2019-04-11 | 2024-02-21 | argenx BV | Anti-IgE antibodies |
MA56102A (fr) | 2019-06-07 | 2022-04-13 | Argenx Bvba | Formulations pharmaceutique d'inhibiteurs de fcrn appropriées pour une administration par voie sous-cutanée |
AU2021206547A1 (en) | 2020-01-08 | 2022-07-14 | argenx BV | Methods for treating pemphigus disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993812A (en) * | 1995-09-14 | 1999-11-30 | Cangene Corporation | Method of delaying the progression of an infection with the human immunodeficiency virus |
JPH0987202A (ja) * | 1995-09-20 | 1997-03-31 | Sumitomo Pharmaceut Co Ltd | 血液凝固異常治療剤 |
AU8266798A (en) * | 1997-06-27 | 1999-01-19 | Biogen, Inc. | Cd154 blockade therapy for autoimmune diseases |
US5980893A (en) * | 1997-07-17 | 1999-11-09 | Beth Israel Deaconess Medical Center, Inc. | Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis |
PL200134B1 (pl) * | 1999-05-07 | 2008-12-31 | Genentech Inc | Zastosowanie przeciwciała anty-CD20 |
US20030095966A1 (en) * | 2000-03-29 | 2003-05-22 | Yang Liu | Method of blocking tissue destruction by autoreactive T cells |
KR20040023565A (ko) * | 2000-09-18 | 2004-03-18 | 아이덱 파마슈티칼즈 코포레이션 | B 세포 고갈/면역조절 항체 조합을 이용한 자가면역질환의 치료를 위한 조합 요법 |
AUPR540301A0 (en) * | 2001-06-01 | 2001-06-28 | Walter And Eliza Hall Institute Of Medical Research, The | A method of purification of cells |
-
2001
- 2001-11-20 DK DK10178480.9T patent/DK2283861T3/en active
- 2001-11-20 DK DK01996390.9T patent/DK1370288T3/da active
- 2001-11-20 US US10/432,442 patent/US20040047862A1/en not_active Abandoned
- 2001-11-20 AT AT01996390T patent/ATE540694T1/de active
- 2001-11-20 CA CA2856033A patent/CA2856033C/en not_active Expired - Lifetime
- 2001-11-20 AU AU2002220404A patent/AU2002220404A1/en not_active Abandoned
- 2001-11-20 WO PCT/CA2001/001648 patent/WO2002040047A2/en not_active Application Discontinuation
- 2001-11-20 CA CA2467781A patent/CA2467781C/en not_active Expired - Lifetime
- 2001-11-20 EP EP01996390A patent/EP1370288B1/de not_active Expired - Lifetime
- 2001-11-20 EP EP10178480.9A patent/EP2283861B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20040047862A1 (en) | 2004-03-11 |
EP1370288B1 (de) | 2012-01-11 |
EP2283861A2 (de) | 2011-02-16 |
CA2467781A1 (en) | 2002-05-23 |
DK2283861T3 (en) | 2016-02-15 |
DK1370288T3 (da) | 2012-03-05 |
WO2002040047A2 (en) | 2002-05-23 |
CA2467781C (en) | 2014-09-23 |
CA2856033A1 (en) | 2002-05-23 |
WO2002040047A3 (en) | 2003-10-02 |
CA2856033C (en) | 2015-11-03 |
EP2283861A3 (de) | 2013-05-29 |
EP2283861B1 (de) | 2016-01-27 |
EP1370288A2 (de) | 2003-12-17 |
AU2002220404A1 (en) | 2002-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE540694T1 (de) | Verfahren zur behandlung der thrombozytopenie mit monoklonalem ivig | |
HUS2100026I1 (hu) | CD20 elleni humán monoklonális ellenanyagok szklerózis multiplex kezelésében történõ alkalmazásra | |
ATE493433T1 (de) | Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen | |
HRP20090527T1 (en) | Nogo-a neutralising immunoglobulins for treatment of neurological diseases | |
TW200716677A (en) | Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders | |
DE602006012513D1 (de) | Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin | |
ATE447587T1 (de) | Anti-il-20-antikörper und bindungspartner und verfahren zur anwendung bei entzündungen | |
AP1918A (en) | Antibodies to CD40 | |
ATE464908T1 (de) | Verfahren zur behandlung von osteoarthritis mit anti-il-6 antikörpern | |
MX346194B (es) | Anticuerpos anti-m-csf. | |
WO2005103083A3 (en) | Anti-cd38 human antibodies and uses therefor | |
TW200724548A (en) | Antibodies to myostatin | |
MY164457A (en) | Human monoclonal antibodies to activin receptor-like kinase-1 | |
CY1109423T1 (el) | Ανθρωπινα μονοκλωνα αντισωματα αντι-ιντελευκινης-5 και μεθοδοι και συνθεσεις που τα περιεχουν | |
ATE409181T1 (de) | Proteomimetische verbindungen und verfahren | |
DE60223340D1 (de) | Serpin-arzneistoffe zur behandlung einer hiv-infektion und verfahren zu deren verwendung | |
JP2003534781A5 (de) | ||
DE60027732D1 (de) | Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems | |
DE60224310D1 (de) | Verfahren zur Herstellung von virusinaktiviertem humanem Gammaglobulin G | |
DE60328747D1 (de) | Reinigung von polyreaktiven Autoantikörpern und deren Verwendungen | |
ATE486892T1 (de) | Verfahren zur kontrolle von krebs | |
DE60335616D1 (de) | Verfahren zur herstellung von siliciumeinkristallen, und dadurch hergestellte siliciumeinkristallwafer und siliciumeinkristallstab | |
ATE368110T1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
ATE473277T1 (de) | Zusammensetzungen und verfahren zur prävention und behandlung von immunvermittelten entzündungskrankheiten | |
RU2019103991A (ru) | Анти-il-22r-антитела |